1007098-98-7

Upstream product

• 1119204-85-1 6-(3,5-difluorophenyl)-2-(3-nitrobenzyl)-2H-pyridazin-3-one 
• 1119204-83-9 3-chloro-6-(3,5-difluorophenyl)pyridazine 
• 1007098-93-2 6-(3,5-difluorophenyl)pyridazine-3(2H)-one 
• 156545-07-2 3,5-difluorophenylboronic acid 
• 123577-99-1 3′,5′-difluoroacetophenone 
• 1877-77-6 3-aminobenzenemethanol 

Downstream Products

• 1119204-87-3 3-chloropropyl {3-[3-(3,5-difluorophenyl)-6-oxo-6H-pyridazin-1-ylmethyl]phenyl}carbamate 
• 1119204-86-2 2,2,2-trichloro-N-{3-[3-(3,5-difluorophenyl)-6-oxo-6H-pyridazin-1-ylmethyl]-phenyl}acetamide 
• 1119204-84-0 3-(4-methylpiperazin-1-yl)propyl {3-[3-(3,5-difluorophenyl)-6-oxo-6H-pyridazin-1-ylmethyl]phenyl}carbamate 
• 1007098-82-9 6-(3,5-difluorophenyl)-2-[3-((S)-2,3-dihydroxypropylamino)benzyl]-2H-pyridazin-3-one 
• 1007098-83-0 2-chloroethyl {3-[3-(3,5-difluorophenyl)-6-oxo-6H-pyridazin-1-ylmethyl]phenyl}carbamate 

Relevant academic research and scientific papers

6-THIOXOPYRIDAZINE DERIVATIVES

Compounds of the formula I, in which R1, R2 and R3 have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.

Pyridiazinone Derivatives for the Treatment of Tumours

Compounds of the formula (I), in which R1, R2 and R3 have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours